OC 32 - Cutting Edge Science in VTE

Moderator(s)

• 

  Robert Ariens, PhD

  Professor
  Discovery and Translational Science Department
  Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK
  Leeds, England, United Kingdom
• 

  Hilary Whitworth, MD

  Instructor
  Pediatrics, Hematology
  Children's Hospital of Philadelphia
  Philadelphia, Pennsylvania, United States

Presentations:

• 10:45 AM – 11:00 AM

  Identifying novel stabilin-2 plasma ligands using proximity labeling
  

  Presenting Author: Mary I. Underwood, PhD – University of Michigan

  Co-Author: Krista L. Golden – University of Michigan

  Co-Author: Karl C. Desch – University of Michigan
• 11:00 AM – 11:15 AM

  Pleiotropic influence of rosuvastatin on apolipoproteins and their association with coagulation factor levels: results from the START trial
  

  Presenting Author: Eleonora Camilleri, MD – Leiden University Medical Center

  Co-Author: Nienke van Rein, PharmD PhD – Leiden University Medical Center

  Co-Author: Bart J. M. van Vlijmen – Department of Internal Medicine, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.

  Co-Author: Joseph S. Biedermann – Department of Haematology, Erasmus MC, Erasmus University Medical Center, Rotterdam, the Netherlands

  Co-Author: Marieke J. Kruip – Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands

  Co-Author: Frank Leebeek, MD, PhD – Department of Hematology, Erasmus MC, University Medical Center Rotterdam, The Netherlands

  Co-Author: Felix van der Meer – Department of Thrombosis and Hemostasis, Leiden University Medical Center

  Co-Author: Christa M. Cobbaert, PhD – ,Leiden University Medical Center, Leiden, The Netherlands

  Co-Author: Suzanne C. Cannegieter, MD PhD – Leiden University Medical Center

  Co-Author: Willem Lijfering – Leiden University Medical Center
• 11:15 AM – 11:30 AM

  Anti-β2-glycoprotein I antibodies cause activated protein C resistance by interfering with Factor V cleavage at Arginine 506
  

  Presenting Author: Tessa Noordermeer, MSc – Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands

  Co-Author: Soumaya Chemlal – Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands

  Co-Author: Jessica E. Molhoek – Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands

  Co-Author: Roger E. G. Schutgens, MD, PhD, MSc – University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands

  Co-Author: Maarten Limper – Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands

  Co-Author: Philip G. de Groot – Synapse Research Institute, Maastricht, the Netherlands

  Co-Author: Joost C.M. Meijers – Department of Molecular Hematology, Sanquin Research, Amsterdam, the Netherlands, Department of Experimental Vascular Medicine, Amsterdam UMC, University of Amsterdam, the Netherlands

  Co-Author: Rolf T. Urbanus – Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
• 11:30 AM – 11:45 AM

  Gut microbiome composition and intestinal immunity in antiphospholipid syndrome patients versus healthy controls
  

  Presenting Author: Valérie L. Jansen, MD – Amsterdam UMC

  Co-Author: Mark Davids – Amsterdam UMC

  Co-Author: Dagmar J. van Mourik – Amsterdam UMC

  Co-Author: Johannes Levels – Amsterdam UMC

  Co-Author: Saskia Middeldorp, MD PhD – Radboud University Medical Center

  Co-Author: Max Nieuwdorp – Amsterdam UMC

  Co-Author: Thijs E. van Mens – Amsterdam UMC
• 11:45 AM – 12:00 PM

  CD146-positive tumors are associated with venous thromboembolism
  

  Presenting Author: Ahmad Joshkon, PhD – INSERM/Aix-Marseille University

  Co-Author: Jimmy Stalin – INSERM/Aix-Marseille University

  Co-Author: Wael Traboulsi – INSERM/Aix-Marseille University

  Co-Author: Lucie Vivancos -Stalin – INSERM/Aix-Marseille University

  Co-Author: Marie Nollet – INSERM/Aix-Marseille University

  Co-Author: Romaric Lacroix, PharmD PhD – Aix-Marseille Univ, APHM, INSERM, INRAE, C2VN, Laboratory of Hematology and Vascular Biology, University Hospital La Conception, Marseille, France

  Co-Author: Richard Bachelier – INSERM/Aix-Marseille University

  Co-Author: Françoise Dignat-George – Aix-Marseille University

  Co-Author: Alexandrine Bertaud – INSERM/Aix-Marseille University

  Co-Author: Aurélie leroyer, PhD – INSERM/Aix-Marseille University

  Co-Author: Nathalie Bardin – Aix-Marseille Univ, APHM, INSERM, INRAE, C2VN -Laboratory of Hematology and Vascular Biology, University Hospital La Conception, Marseille, France.

  Co-Author: Marcel Blot-Chabaud – INSERM/Aix-Marseille University